Thu, September 6, 2012
Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
Mon, August 27, 2012
Sun, August 26, 2012
Sat, August 25, 2012
Fri, August 24, 2012
Thu, August 23, 2012

ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. -stifel-nicolaus-2012-healthcare-conference.html
Published in Health and Fitness on Thursday, August 30th 2012 at 12:18 GMT by Market Wire   Print publication without navigation


ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference -- EXTON, Pa., Aug. 30, 2012 /PRNewswire/ --

ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference

[ ]

EXTON, Pa., Aug. 30, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: [ VPHM ]) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present at the Stifel Nicolaus 2012 Healthcare Conference at 1:30 P.M. ET on Wednesday, September 5, 2012.  The conference is being held at the Four Seasons Hotel in Boston.

ViroPharma's presentations will be webcast live for investors through [ www.viropharma.com ] and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options.  ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, Friedreich's Ataxia, adrenal insufficiency; and recurrent C. difficile infection (CDI).  Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve.  ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures and C. difficile-associated diarrhea (CDAD); for full U.S. prescribing information on our products, please download the package inserts at [ http://www.viropharma.com/Products.aspx ]; the prescribing information for other countries can be found at [ www.viropharma.com ]. 

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, [ www.viropharma.com ]. The company encourages investors to consult these sections for more information on ViroPharma and our business.

SOURCE ViroPharma Incorporated



[ Back to top ]

RELATED LINKS
[ http://www.viropharma.com ]


Publication Contributing Sources